If Janssen hasn't moved to license or put cash forward for an extension by 2H it would be a point of concern. Roche also had a February date in 2013 with anticipated move to license which just drifted past the Feb crux & Pfizer also looking at early 2013. They only delivered the end of AZ/Roche/Pfizer agreements slipped into the annual report lets hope it doesn't play out the same.
If Janssen hasn't moved to license or put cash forward for an...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |